Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suad Alateeq

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Stem Cell Research & Therapy|February 21, 2015
Advances in reprogramming to pluripotencySuad Alateeq, Patrick R J Fortuna, Ernst Wolvetang
APL Bioengineering|May 10, 2019
Identification of on-target mutagenesis during correction of a beta-thalassemia splice mutation in iPS cells with optimised CRISPR/Cas9-double nickase reveals potential safety concernsSuad Alateeq, Dmitry Ovchinnikov, Timothy Tracey, et al.
Stem Cell Reports|August 9, 2020
Direct Comparison of Four Hematopoietic Differentiation Methods from Human Induced Pluripotent Stem CellsMelinda L Tursky, To Ha Loi, Crisbel M Artuz, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Stem Cell Research & Therapy|February 21, 2015
Advances in reprogramming to pluripotencySuad Alateeq, Patrick R J Fortuna, Ernst Wolvetang
APL Bioengineering|May 10, 2019
Identification of on-target mutagenesis during correction of a beta-thalassemia splice mutation in iPS cells with optimised CRISPR/Cas9-double nickase reveals potential safety concernsSuad Alateeq, Dmitry Ovchinnikov, Timothy Tracey, et al.
Stem Cell Reports|August 9, 2020
Direct Comparison of Four Hematopoietic Differentiation Methods from Human Induced Pluripotent Stem CellsMelinda L Tursky, To Ha Loi, Crisbel M Artuz, et al.
Pageof 1